Bayer/GSK Levitra Sales Top $100 Mil.; New ED Patient Share Growing
Executive Summary
More than 40% of new prescriptions for Bayer/ GlaxoSmithKline's Levitra are for previously undiagnosed erectile dysfunction patients, Bayer CFO Klaus Kuhn told investors Nov. 11
You may also be interested in...
Bayer Focuses Internally: In-Licensing, In-House R&D Are Priorities
Bayer will focus on seeking licensing deals for its pharmaceutical business after abandoning a search for a more extensive partnership, CEO Werner Wenning told analysts Nov. 11
Quarterly Call Round-Up: Pfizer, GSK, Lilly Updates
Pfizer sees more savings from Pharmacia: Pfizer is now projecting "at least" $1 bil. in synergies from the Pharmacia acquisition in 2003, indicating that it expects to exceed its original target of $1 bil. in first-year savings...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011